Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now

Trump’s $2.5 Trillion Moneybomb Detonates Soon

Published 04/07/2017, 06:33 AM
Updated 05/14/2017, 06:45 AM

In this week’s chart edition, where we select a handful of graphics to convey important economic or investment insights, I’m focusing on the $2.5 trillion “Moneybomb” destined to hit U.S. shores this year.

You’ll recall, President Donald Trump promised to slash corporate taxes and set up a one-time tax holiday to repatriate cash held in foreign countries.

If the health care reform failure is any indication, tax reform or even just a tax holiday won’t come easy. But it’ll come.

And once it does, it promises to trigger one of the largest one-time wealth transfers in the history of capitalism.

How do we grab our share of the fortune? As you’ll see in a moment, it shouldn’t be too difficult.

Bring Home the Money

U.S. companies are hoarders. Because of onerous tax regulations, they’ve stashed an estimated $2.5 trillion in profits in overseas tax havens. That amounts to about 10% of the entire market cap of the S&P 500 index. So this isn’t mere pocket change.

Granted, not all of that money is parked in cash. Some is tied up in plant and inventories — making it illiquid. But there’s still a ridiculous amount of cash desperate to make its way back home at lower tax rates.

And the first part of profiting from this gigantic repatriation windfall is distinguishing between sectors and companies with empty pockets and ones with Costanza wallets overstuffed with cash.

Armed with the data, it’s abundantly clear what sectors are the highest-value targets — technology and health care.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Untaxed Foreign Profits By Sector

At the end of 2015, S&P 500 technology and healthcare companies collectively reported over a trillion dollars of untaxed foreign profits — or roughly 50% of the total. No other sectors come close to hoarding as much.

Drilling down to the company level, it’s clear the cash is not only concentrated in a handful of sectors, but a handful of companies, too.

Estimated Cash Overseas, By Company

For investors, there are two ways to play this reality…

Almost Forgotten History

Most investors fail to realize that the U.S. enjoyed a one-time tax holiday in 2004, making it easy to predict what companies will do this time around. The same thing!

In 2004, U.S. firms repatriated over $300 billion, and stock buybacks rose 84%, according to an analysis by Goldman Sachs. In this case, correlation does imply causation.

Buybacks have already been a major outlet of excess cash — and, in turn, the driver of the latest bull market. That’s because fewer shares outstanding increases earnings per share. Check out the NASDAQ Buyback Achievers Index for proof.

The index tracks the stock performance of U.S. companies that have repurchased 5% or more of outstanding shares over the trailing 12 months.

NASDAQ Buyback Achievers Index Performance

Giving executives even more cash promises to increase such activity.

Or as Goldman’s chief U.S. equity strategist David Kostin says, “A significant portion of returning funds will be directed to buybacks based on the pattern of the tax holiday in 2004.”

The easiest way to benefit from this trend is to buy the index.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Instead of trying to predict the individual companies that will boost buyback activity the most, we can own them all via the PowerShares BuyBack Achievers ETF (PKW).

Of course, buybacks won’t be the only outlet for cash. Many firms will plow repatriated cash into mergers and acquisitions.

As Ethan Lovell, a portfolio manager at Janus Capital Group, told Bloomberg, “The vast majority of companies that I speak with want to make acquisitions. Their first order of business is build the business and enhance the growth rate.”

The most obvious targets are small- and midcap players with innovative technologies or treatments. Like Visteon Corp. (NYSE:VC) or Zynerba Pharmaceuticals Inc. (NASDAQ:ZYNE). Both are compelling buys at current prices.

Contrarian or Victim?

Here’s the best part about the Trump “Moneybomb” trade — Wall Street is completely downplaying the possibility, which sets the stage for even bigger gains.

A recent analysis by Jefferies found the companies that stand to benefit the most from tax reform are performing the worst since the election.

S&P 500 Performance Based On Tax Rate Quintiles

As one mentor likes to remind me, there are only two classes of investors on Wall Street — contrarians and victims.

Right now, the victims are lining up, betting against any meaningful tax reform or holiday. Don’t join them. Bet against them.

Latest comments

Hmmm, the markets is not something to bet on, IT is something to work with, just my opinion, but thank you very much for your analysis and updates...
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.